Drug profile · INN
dexrazoxane hydrochloride
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride (DEXRAZOXANE HYDROCHLORIDE) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — dexrazoxane hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
dexrazoxane hydrochloride (DEXRAZOXANE HYDROCHLORIDE) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA topoisomerase II inhibitor
Primary target: DNA topoisomerase II
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dexrazoxane hydrochloride?
dexrazoxane hydrochloride (DEXRAZOXANE HYDROCHLORIDE) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dexrazoxane hydrochloride?
DEXRAZOXANE HYDROCHLORIDE is a marketed brand name for dexrazoxane hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexrazoxane hydrochloride?
dexrazoxane hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.